In this report, global Bio Pharma Buffer Market will reach 929.47 Million USD by the end of 2022 with a CAGR of 7.81%
The global Bio Pharma Buffer market was valued at 638.29 Million USD in 2017 and will reach 929.47 Million USD by the end of 2022, growing at a CAGR of 7.81% during 2017-2022.
A buffer solution is comprised of a weak conjugate acid-base pair, for example, a weak acid and its conjugate base, or a weak base and its conjugate acid. Small quantities of other acids or bases are neutralized when added to the solution, and as a result, the solution resists changes in pH. Solutions with stable pH are required for the processing of protein-based biologic APIs because of their sensitivity to changes in pH. The stable pH range and capacity (the amount of acid/base that can be added without a change in pH) of a buffer are determined by the conjugate acid-base pair.
Download Free Sample Report @ https://www.radiantinsights.com/research/global-bio-pharma-buffer-market-2020-2026/request-sample
Bio Pharma Buffer can be divided into four categories: Phosphates Type, Acetates Type and TRIS Type. Phosphates Type accounted for the highest proportion in revenue market, with a figure of 28.68% in 2017, followed by TRIS Type, account for 22.65% and Acetates Type account for 13.33%.
The sales market share of global Bio Pharma Buffer in Research Institution use, \Pharmaceutical Industry use and other applictions have been stable year by year, at 42.10%, 50.48% and 7.42% respectively in 2017, and for several consecutive years, the amplitude was within one percent. This indicates that the segment of the Bio Pharma Buffer in the global market tends to be fixed without great changes. Among them, the Bio Pharma Buffer market has the most promising sales prospects in Pharmaceutical Industry use.
Radiant Insights, Inc. data shows that North America is the biggest contributor to the Bio Pharma Buffer revenue market, accounted for 47.35% of the total global market with a revenue of 302.21 million USD in 2017, followed by Europe, 27.90% with a revenue of 178.10 million USD.
Merck is the largest company in the global Bio Pharma Buffer market, accounted for 20.82% of the revenue market share in 2017, followed by Avantor and Alfa Aesar (Thermo Fisher), accounted for 18.19% and 16.45% of the revenue market share in 2017. According to the revenue of these companies, we can know that the Bio Pharma Buffer industry is relative concentrated. Because the top 6 companies have more than 70% market share in 2016.
This report focuses on top manufacturers in global market, Involved the assessment of Sales, price, revenue and market share for each manufacturer, covering
• Avantor
• Alfa Aesar (Thermo Fisher)
• Merck
• Lonza
• Bio-Rad
• BD
• GE Healthcare
• Promega Corporation
• Hamilton Company
• XZL BIO-TECHNOLOGY
• SRL
On the basis of product, this report displays the Sales, revenue, price, market share and growth rate of each type, primarily split into
• Phosphates Type
• Acetates Type
• TRIS Type
• Others
By Application, this report focuses on Sales, Market share and Growth Rate of each application, can be divided into
• Research Institution
• Pharmaceutical Industry
• Others
By Regions, this report splits global market into several key regions, with Sales, Revenue, Price and Gross Margin market share of top players in these regions, from 2014 to 2026 (forecast), like
• China
• USA
• Europe
• Japan
• Korea
• India
• Southeast Asia
• South America
Browse Full Research Report with TOC @ https://www.radiantinsights.com/research/global-bio-pharma-buffer-market-2020-2026
Table of Contents
Global Bio Pharma Buffer Market Professional Survey Report 2019
1 Report Overview
1.1 Definition and Specification
1.2 Manufacturers and Region Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.3 Type Overview
1.3.1 Phosphates Type
1.3.2 Acetates Type
1.3.3 TRIS Type
1.3.4 Others
1.4 Application Overview
1.4.1 Research Institution
1.4.2 Pharmaceutical Industry
1.4.3 Others
1.5 Industrial Chain
1.5.1 Bio Pharma Buffer Industrial Chain
1.5.2 Upstream
1.5.3 Downstream
2.1 The Overall Market Performance(Volume)
2.1.1 Phosphates Type
2.1.2 Acetates Type
2.1.3 TRIS Type
2.1.4 Others
2.2 The Overall Market Performance(Value)
2.2.1 Phosphates Type
2.2.2 Acetates Type
2.2.3 TRIS Type
2.2.4 Others
3 Global Bio Pharma Buffer Market Assessment by Application
3.1 Overall Market Performance (Volume)
3.2 Research Institution
3.3 Pharmaceutical Industry
3.4 Others
Continued…
Read all Reports of this category @ https://www.radiantinsights.com/catalog/pharmaceuticals-and-healthcare
About Radiant Insights
Radiant Insights is a platform for companies looking to meet their market research and business intelligence requirements. It assists and facilitate organizations and individuals procure market research reports, helping them in the decisions making process. The Organization has a comprehensive collection of reports, covering over 40 key industries and a host of micro markets. In addition to over extensive database of reports, experienced research coordinators also offer a host of ancillary services such as, research partnerships/ tie-ups and customized research solutions.
Media Contact:
Company Name: Radiant Insights, Inc
Contact Person: Michelle Thoras
Phone: (415) 349-0054
Toll Free: 1-888-928-9744
Address: 201 Spear Street 1100, Suite 3036,
City: San Francisco; State: California; Country: United States
Email: [email protected]
Website: https://www.radiantinsights.com/
